159 related articles for article (PubMed ID: 38295320)
1. 5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma.
Chennakesavalu M; Moore K; Chaves G; Veeravalli S; TerHaar R; Wu T; Lyu R; Chlenski A; He C; Piunti A; Applebaum MA
JCO Precis Oncol; 2024 Jan; 8():e2300297. PubMed ID: 38295320
[TBL] [Abstract][Full Text] [Related]
2. 5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma.
Chennakesavalu M; Moore K; Chaves G; Veeravalli S; TerHaar R; Wu T; Lyu R; Chlenski A; He C; Piunti A; Applebaum MA
bioRxiv; 2023 Apr; ():. PubMed ID: 37163024
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
Applebaum MA; Barr EK; Karpus J; West-Szymanski DC; Oliva M; Sokol EA; Zhang S; Zhang Z; Zhang W; Chlenski A; Salwen HR; Wilkinson E; Dobratic M; Grossman RL; Godley LA; Stranger BE; He C; Cohn SL
Clin Cancer Res; 2020 Mar; 26(6):1309-1317. PubMed ID: 31852832
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
Pediatr Blood Cancer; 2024 Jan; 71(1):e30735. PubMed ID: 37859597
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.
Applebaum MA; Barr EK; Karpus J; Nie J; Zhang Z; Armstrong AE; Uppal S; Sukhanova M; Zhang W; Chlenski A; Salwen HR; Wilkinson E; Dobratic M; Grossman R; Godley LA; Stranger BE; He C; Cohn SL
JCO Precis Oncol; 2019; 3():. PubMed ID: 31179414
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Sep; ():. PubMed ID: 37693610
[TBL] [Abstract][Full Text] [Related]
7. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells.
Chapman-Rothe N; Curry E; Zeller C; Liber D; Stronach E; Gabra H; Ghaem-Maghami S; Brown R
Oncogene; 2013 Sep; 32(38):4586-92. PubMed ID: 23128397
[TBL] [Abstract][Full Text] [Related]
8. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Shen Y; Wang L; Ou J; Wang B; Cen X
Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
[No Abstract] [Full Text] [Related]
9. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.
Weigert M; Cui XL; West-Szymanski D; Yu X; Bilecz AJ; Zhang Z; Dhir R; Kehoe M; Zhang W; He C; Lengyel E
Gynecol Oncol; 2024 Mar; 182():82-90. PubMed ID: 38262243
[TBL] [Abstract][Full Text] [Related]
11. Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
Chicard M; Colmet-Daage L; Clement N; Danzon A; Bohec M; Bernard V; Baulande S; Bellini A; Deveau P; Pierron G; Lapouble E; Janoueix-Lerosey I; Peuchmaur M; Corradini N; Defachelles AS; Valteau-Couanet D; Michon J; Combaret V; Delattre O; Schleiermacher G
Clin Cancer Res; 2018 Feb; 24(4):939-949. PubMed ID: 29191970
[No Abstract] [Full Text] [Related]
12. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
[TBL] [Abstract][Full Text] [Related]
13. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
17. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
18. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways.
Bhattacharyya S; Pradhan K; Campbell N; Mazdo J; Vasantkumar A; Maqbool S; Bhagat TD; Gupta S; Suzuki M; Yu Y; Greally JM; Steidl U; Bradner J; Dawlaty M; Godley L; Maitra A; Verma A
Genome Res; 2017 Nov; 27(11):1830-1842. PubMed ID: 28986391
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
[TBL] [Abstract][Full Text] [Related]
20. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
Court F; Arnaud P
Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
